June 8, 2026 - 10:49

Genworth Financial continues to lean heavily on its majority stake in Enact Holdings, a mortgage insurance provider that now stands as the company's most valuable asset. With Enact currently valued at roughly $4.7 billion, Genworth's own market capitalization remains surprisingly low in comparison. This disconnect suggests that the broader market has not fully priced in the worth of Genworth's core holding.
Analysts point out that Genworth's stock trades at a significant discount to the implied value of its Enact shares alone. If you strip out the value of the Enact stake, the rest of Genworth's business -- including its legacy life insurance and long-term care operations -- appears to be valued at a fraction of what it might be worth. This creates a compelling opportunity for investors who see the gap narrowing over time.
The company has also made progress in managing its older insurance liabilities, which have long been a drag on its balance sheet. While those legacy risks are not gone, they are better contained than in previous years. As Enact continues to generate steady profits, Genworth is in a stronger position to address its remaining obligations.
For now, the stock remains a buy for those willing to bet that the market will eventually recognize the true value of the Enact holding. The discount is wide, but the driver is clear.
October 21, 2026 - 11:51
AI Reshapes Software Industry as Winners and Losers EmergeCiti analyst Tyler Radke says artificial intelligence is dividing the software sector into clear winners and losers, as companies that have built strong AI capabilities pull ahead while others...
October 20, 2026 - 19:15
Nebraska School Finance Commission Revisits State Funding Share, Backs Legislative ProposalsThe School Financing Review Commission approved its annual recommendations to the Nebraska Legislature Tuesday, reopening a long-running debate over how much the state should contribute to public...
October 20, 2026 - 04:51
Rock Financial Plans Major Announcement for DetroitRock Financial is set to make what it describes as a special and unprecedented announcement for Detroit on Monday morning. The company will share the news during a livestream event, drawing...
October 19, 2026 - 01:41
City Therapeutics (CTY) Debuts Strongly But Fair Value Remains Hard To Pin DownCity Therapeutics (CTY) has moved quickly since its Nasdaq listing, combining a roughly $200 million initial public offering with a new $239.1 million shelf registration covering 13.3 million...